| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Vice President and CFO | Stock Options | 200K | Nov 6, 2022 | Direct | ||
| Guardion Health Sciences, Inc. | Director | Employee Stock Option (right to buy) | 334 | Jun 30, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GHSI | Guardion Health Sciences, Inc. | Jun 30, 2023 | 1 | $0 | 4 | Jul 5, 2023 | Director |
| LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Nov 6, 2022 | 1 | $0 | 4 | Nov 9, 2022 | Vice President and CFO |
| GHSI | Guardion Health Sciences, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
| GHSI | Guardion Health Sciences, Inc. | Aug 20, 2021 | 1 | $11.4K | 4 | Aug 23, 2021 | Director |
| GHSI | Guardion Health Sciences, Inc. | Jun 30, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |